Unique Pharmaceutical Laboratories has issued a voluntary recall for four specific lots of Cetirizine Hydrochloride Tablets USP 5 mg due to potential cross-contamination with ranitidine. The recall, initiated July 18 and published by the U.S. Food and Drug Administration (FDA) on July 20, follows the discovery of discolored tablets containing red dots by a pharmacy … Read more
Alpha-gal syndrome is a tick-borne condition causing allergic reactions to mammalian products, primarily red meat. While dietary restrictions remain the primary treatment, patients are increasingly scrutinizing skincare and household products for hidden mammal-derived ingredients. According to Dr. Seth Knight, an allergist and immunologist with Cox Health, current evidence confirms red meat as the primary trigger … Read more
MCBS, LLC, a healthcare billing support provider, notified patients of Stephen W. Brown & Radiology Associates of Augusta that an unauthorized individual may have accessed their personal and medical information. The security incident occurred between September 22 and September 26, 2025, potentially exposing sensitive data including Social Security numbers, dates of birth, and medical histories. … Read more
Researchers in eastern Congo have launched a clinical trial for two experimental Ebola treatments to combat the ongoing outbreak of the Bundibugyo virus. According to the World Health Organization (WHO), the trial aims to evaluate the effectiveness of Gilead Sciences’ remdesivir and Mapp Biopharmaceutical’s MBP134, as the virus has already claimed 438 lives out of … Read more
The Bundibugyo strain of Ebola, which lacks approved vaccines or treatments, has caused 894 confirmed cases and over 200 deaths in eastern Congo, according to the Africa Centres for Disease Control and Prevention. The outbreak, centered in Ituri, has reached North and South Kivu provinces and crossed into Uganda, where 19 cases and two deaths … Read more
Federal health advisers have recommended approval for the first mRNA-based influenza vaccine, a move that could shift how the U.S. addresses seasonal flu. The Food and Drug Administration (FDA) is currently evaluating Moderna’s “mFlusiva” for adults ages 50 and older. If authorized, this vaccine would leverage the same messenger RNA technology used in COVID-19 shots … Read more
China’s nutraceutical market, valued at US$17 billion in 2025, represents a critical growth frontier for foreign brands, according to data from digital commerce agency WPIC. While domestic brands remain competitive, 54% of Chinese consumer spending on health supplements currently favors international labels. Success in this ecosystem requires navigating unique platforms like Tmall, Douyin, and WeChat, … Read more
The American College of Obstetricians and Gynecologists (ACOG) released a new, independent immunization schedule for pregnant and breastfeeding individuals this week, diverging from current U.S. Centers for Disease Control and Prevention (CDC) guidelines. According to Dr. Christopher Zahn, ACOG’s chief of clinical practice, the move aims to provide evidence-based clarity amid shifting federal recommendations and … Read more
GLP-1 medications like Ozempic and Wegovy produce highly variable results, with some patients losing over 20 percent of their body weight while others see minimal change or even gain weight. According to research from the 23andMe Research Institute and insights from Dr. Anthony Puopolo, this disparity is driven by a complex mix of genetics, eating … Read more
The Race Against Bundibugyo: How Science and Resilience are Changing the Ebola Fight In the rugged terrain of eastern Congo, a quiet but fierce battle is underway. The current outbreak of the Bundibugyo virus—a rare and particularly challenging strain of Ebola—has pushed health systems to their limits. However, amidst the struggle, a new narrative is … Read more